disclosures
play

Disclosures I have no disclosures. NEUROINFECTIOUS DISEASES : - PowerPoint PPT Presentation

2/8/2017 Disclosures I have no disclosures. NEUROINFECTIOUS DISEASES : PRACTICAL TIPS FOR COMMON DISORDERS Felicia Chow, MD, MAS Assistant Professor of Neurology and Medicine (ID) February 8, 2017 Learning objectives Neurosyphilis


  1. 2/8/2017 Disclosures • I have no disclosures. NEUROINFECTIOUS DISEASES : PRACTICAL TIPS FOR COMMON DISORDERS Felicia Chow, MD, MAS Assistant Professor of Neurology and Medicine (ID) February 8, 2017 Learning objectives Neurosyphilis • Recognize the clinical presentation of common neuroinfectious diseases • Identify pitfalls of diagnostic testing frequently obtained in the evaluation and management of common neuroinfectious diseases • Be familiar with the approach to the treatment of common neuroinfectious diseases Camarero-Temino Nephrology 2013 1

  2. 2/8/2017 Stages of syphilis Question: My patient has neurosyphilis. Does that automatically mean they have late, or like later, or latent syphilis? Camarero-Temino Nephrology 2013 Lafond et al. Clin Microbiol Rev 2006 Question: I have a patient whose MRI demonstrated a small acute infarct in the internal capsule. He has hypertension and Reply: Neurosyphilis can occur at any uncontrolled diabetes, and urine tox screen was stage of infection. positive for cocaine. His RPR was 1:64 and was negative 6 months ago. Since strokes in syphilis usually occur as a late presentation and he has many other vascular risk factors, I don’t have to LP him, do I? 2

  3. 2/8/2017 Think meninges, CSF and blood vessels in early syphilis and parenchymal disease in late syphilis Reply: I would recommend an LP for any patient with a newly positive RPR (or positive RPR of unknown duration) and clinical/radiologic evidence of strokes. Ghanem CNS Neurosci Ther 2010 Which syphilis patients need an LP? Question: My clinic patient has uveitis • Any stage of syphilis + neurological symptoms and an RPR of 1:128. Ophtho sent him to • Any stage of syphilis + ocular or otologic disease clinic for neurological evaluation, but he • HIV-infected patients PLUS: has no neurological symptoms. I don’t • Late latent syphilis have to LP him, do I? • Syphilis of unknown duration • Inappropriate serologic response after treatment • Consider for any HIV-infected patient with CD4 <350 cells/mm 3 and/or RPR ≥ 1:32 Ghanem Clin Infect Dis 2009 3

  4. 2/8/2017 Beware the ongoing ocular syphilis epidemic Reply: I would recommend an LP for all • Can occur at any stage of syphilis � most cases now present in early syphilis patients with ocular syphilis. • Can involve ANY ocular structure • Anterior uveitis (iris, ciliary body) • Posterior uveitis (chorioretinitis) • Retinitis, retinal detachment • Optic neuritis • ~50% of patients with ocular syphilis will have evidence of meningitis in the CSF • Treatment is the same as neurosyphilis even if CSF is non-inflammatory • May have residual vision loss despite treatment Woolston et al. MMWR 2015 Syphilis diagnostic testing Question: My HIV+ patient, intermittently Test characteristics Notes non-adherent to his ARVs, presented to SERUM Sensitivity: *Titers correspond to disease 1° : 78-86% activity clinic with headaches that are more RPR (non- 2° : Near 100% treponemal 3° /Latent: Varies, ~85% *Used to assess treatment severe than his usual migraines. tests) response � 4-fold decline False positives 1-2%, usually titer < 1:8 considered to be clinically (autoimmune disease, IVDU, TB, significant pregnancy, endocarditis) Serum RPR was 1:64. CSF had 20 WBC False negatives in HIV, prozone effect and a mildly elevated protein, but CSF SERUM False positives with other spirochetal *Titers do not correspond to infections, malaria, leprosy disease activity Treponemal *Most positive for life despite VDRL was negative. Could this still be tests False negative in HIV treatment (TPPA, *15-25% treated in primary stage neurosyphilis? FTA-Abs) revert to seronegativity CSF VDRL CSF VDRL Sensitivity : 30-80%, *+CSF VDRL at any titer = and FTA- Specificity 99% neurosyphilis Abs FTA-abs high sensitivity but low specificity 4

  5. 2/8/2017 HSV-1 encephalitis Reply: Yes, CSF VDRL can be insensitive for neurosyphilis. This absolutely could still be neurosyphilis, and based on the clinical data, I would recommend treating him for neurosyphilis with 2 weeks of Penicillin G (4 million units IV q4 hours). Question: We have an inpatient who presented HSV encephalitis with 2 days of fever, headache and confusion. CSF with 11 WBC (85%L), protein 75 and glucose 53. • HSV is the most frequently identified viral etiology of sporadic encephalitis in the US • Occurs any time of year • Bimodal distribution: 1/3 cases <20 y, 2/3 >40 y • Case fatality rate >70% if untreated; 1/3 of patients may be significantly disabled despite treatment • CSF: 5-500 WBC/mm 3 , normal to moderately elevated protein, glucose typically normal • DWI may be most sensitive sequence early in the CSF HSV 1 PCR negative. Could this still be course of infection HSV encephalitis? 5

  6. 2/8/2017 What is the utility of HSV-1 PCR in the CSF? Sensitivity of CSF HSV-1 PCR is lower early in the course of HSV encephalitis • 54 patients with biopsy- proven HSE underwent HSV-1 PCR from CSF • Sensitivity 98% • Specificity 94% Lakeman J Infect Dis 1995 Weil Clin Infect Dis 2002 Reply: Yes, this could definitely still be Question: The repeat CSF HSV-1 PCR HSV-1 encephalitis. I recommend you was positive. She received 3 weeks of IV repeat the lumbar puncture, resend an acyclovir but is still quite impaired, far from HSV-1 PCR from the CSF and start IV her baseline. Should we discharge her on acyclovir 10-15 mg/kg every 8 hours as oral antiviral therapy? you await the results. 6

  7. 2/8/2017 No significant cognitive benefit of oral therapy after IV acyclovir Reply: No, unfortunately there is no • 87 HSE patients evidence that a longer course of oral randomized to valacyclovir 2 g TID versus placebo x antiviral therapy after completing IV 90 days acyclovir is beneficial, and I do not • Excluded individuals with recommend she be discharged on oral life expectancy <90 d and those who couldn’t take therapy. PO • Primary outcome was survival with no/mild impairment at 12 months Gnann Clin Infect Dis 2015 Relapsing symptoms after HSV encephalitis • ~15-25% of patients have early relapsing symptoms after Question: Our HSV-1 encephalitis patient completing acyclovir was readmitted from rehab 4 weeks after • More common in children � chorea, dystonia, fever, AMS, behavioral changes, seizures she was discharged with worsening confusion. Could this be recurrent HSV • Adults � movement symptoms less common infection? • CSF pleocytosis and elevated protein; contrast enhancement on MRI • Immune-mediated hypothesis supported by recent discovery of NMDAR and other antibodies patients with relapsing symptoms Armangue Neurology 2015 7

  8. 2/8/2017 Diagnostic approach to relapsing symptoms in HSV RELAPSING NEUROLOGICAL SYMPTOMS Reply: I would repeat a lumbar (e.g., CHOREOATHETOSIS, CONFUSION, AGGRESSION, AGITATION, SEIZURES ) puncture and resend the CSF HSV-1 PCR. If the HSV-1 PCR is negative, I would NOT restart IV acyclovir and CSF HSV-1 PCR PCR + CSF/SERUM FOR ANTIBODIES TO ACYCLOVIR would consider serum/CSF evaluation NMDAR, OTHERS for NMDAR antibodies if there is no PCR - identified cause for a persistent decline. NEGATIVE CONSIDER ANTIBODY RESULTS IMMUNOTHERAPY POSITIVE IMMUNOTHERAPY Titulaer Mov Disorder 2014 Toxoplasmosis Question: Our patient with newly diagnosed HIV infection (CD4 count 90 cells/mm 3 , viral load 75K) presented with progressive right sided weakness and confusion. https://www.urmc.rochester.edu/libraries/courses/neuroslides/lab3b/slide137.cfm 8

  9. 2/8/2017 CNS toxoplasmosis I know the serum • Most common focal brain toxoplasma lesion in HIV+ w/ CD4 < 200 in US antibody status of an HIV+ patient • Presentation usually evolves with focal brain over weeks to months lesions is key. The patient’s serum • TMP/SMX prophylaxis toxo IgM ELISA is reduces risk of negative, so does toxoplasmosis this rule out toxoplasmosis? • Ddx: CNS lymphoma, pyogenic abscess, tuberculoma, cryptococcoma Tan et al. Lancet Neurology 2012, Laing et al. Int J STD AIDS 1996 Utility of toxoplasma serology • Toxoplasmosis seropositivity in general population in the Reply: The serum toxoplasma IgG is US is estimated to be 10-40% typically more informative in an HIV • Toxoplasmosis in HIV is typically reactivation of prior patient in whom you are worried about infection (i.e., IgM antibodies unhelpful) toxoplasmosis. Send the IgG and, if safe, do a lumbar puncture and send the CSF • Serum IgG is positive in most HIV patients with CNS toxoplasmosis for toxoplasma IgG and/or toxo PCR. • CSF toxo IgG (>1:64) and PCR are very specific but sensitivity varies Laing Int J STD AIDS 1996, Correira Trans R Soc Trop Med Hyg 2010, Vidal J Clin Microbiol 2004, Sakamoto Parasitol Int 2014 9

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend